Literature DB >> 29568997

[Severe skin reactions due to new medications].

M Mockenhaupt1, M Paulmann2.   

Abstract

Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and a specific form of hypersensitivity syndrome which is nowadays called "drug reaction with eosinophilia and systemic symptoms" (DRESS) are severe, mainly drug-induced skin reactions. Whereas SJS/TEN is considered one reaction entity of different severity, DRESS has to be distinguished from SJS/TEN but also from other severe exanthems due to multiorgan involvement. Although SJS/TEN is generally referred to as drug reaction, in total only about three quarters of the cases are actually caused by drugs. After the clinical diagnosis is made, identification of the potential inducing factor is most important. In case medications are considered as causal, their withdrawal plays a key role in management. In order to identify and withdraw the inducing agent, a detailed and thorough medication history must be obtained. Agents identified or confirmed as inducers of SJS/TEN by pharmacoepidemiological studies are allopurinol, antibacterial sulfonamides, various antiepileptics, nevirapine and nonsteroidal anti-inflammatory drugs of the oxicam-type. Among drugs inducing DRESS are also various antiepileptics, but in addition allopurinol, sulfonamides and minocycline. Some cases of SJS/TEN and DRESS associated with the use of new medication, including targeted therapies and biologicals, have been observed.

Entities:  

Keywords:  Drug eruptions; Drug reaction with eosinophilia and systemic symptoms; Medication history; Stevens-Johnson syndrome; Toxic epidermal necrolysis

Mesh:

Substances:

Year:  2018        PMID: 29568997     DOI: 10.1007/s00105-018-4153-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  36 in total

1.  Medical genetics: a marker for Stevens-Johnson syndrome.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Hong-Shang Hong; Mo-Song Hsih; Li-Cheng Yang; Hsin-Chun Ho; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

2.  Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry.

Authors:  B Rzany; M Mockenhaupt; S Baur; W Schröder; U Stocker; J Mueller; N Holländer; R Bruppacher; E Schöpf
Journal:  J Clin Epidemiol       Date:  1996-07       Impact factor: 6.437

3.  Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Authors:  S H Kardaun; A Sidoroff; L Valeyrie-Allanore; S Halevy; B B Davidovici; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2007-03       Impact factor: 9.302

4.  Epidemiology of staphylococcal scalded skin syndrome in Germany.

Authors:  Maja Mockenhaupt; Marco Idzko; Martine Grosber; Erwin Schöpf; Johannes Norgauer
Journal:  J Invest Dermatol       Date:  2005-04       Impact factor: 8.551

5.  Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy.

Authors:  Maren Paulmann; Maja Mockenhaupt
Journal:  J Dtsch Dermatol Ges       Date:  2015-07       Impact factor: 5.584

6.  A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions.

Authors:  A Barbaud; E Collet; B Milpied; H Assier; D Staumont; M Avenel-Audran; A Grange; S Amarger; P Girardin; M-T Guinnepain; F Truchetet; A Lasek; J Waton
Journal:  Br J Dermatol       Date:  2013-03       Impact factor: 9.302

7.  Drug hypersensitivity: pharmacogenetics and clinical syndromes.

Authors:  Elizabeth J Phillips; Wen-Hung Chung; Maja Mockenhaupt; Jean-Claude Roujeau; Simon A Mallal
Journal:  J Allergy Clin Immunol       Date:  2011-03       Impact factor: 10.793

8.  Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.

Authors:  Ariane Auquier-Dunant; Maja Mockenhaupt; Luigi Naldi; Osvaldo Correia; Werner Schröder; Jean-Claude Roujeau
Journal:  Arch Dermatol       Date:  2002-08

9.  Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.

Authors:  Sima Halevy; Pierre-Dominique Ghislain; Maja Mockenhaupt; Jean-Paul Fagot; Jan Nico Bouwes Bavinck; Alexis Sidoroff; Luigi Naldi; Ariane Dunant; Cecile Viboud; Jean-Claude Roujeau
Journal:  J Am Acad Dermatol       Date:  2007-10-24       Impact factor: 11.527

10.  Stevens-Johnson syndrome and toxic epidermal necrolysis induced by amifostine during head and neck radiotherapy.

Authors:  Laurence Valeyrie-Allanore; Nicolas Poulalhon; Jean-Paul Fagot; Peggy Sekula; Batya Davidovici; Alexis Sidoroff; Maja Mockenhaupt
Journal:  Radiother Oncol       Date:  2008-03-06       Impact factor: 6.280

View more
  2 in total

1.  [Cutaneous side effects of targeted therapies].

Authors:  H F Merk; C C Zouboulis
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

Review 2.  [Acute life-threatening drug reactions of the skin].

Authors:  M Mockenhaupt
Journal:  Hautarzt       Date:  2018-05       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.